A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

NCT06114745 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease (AD)

Interventions

DRUG: SHR-1707 injection
DRUG: Placebo

Sponsor

Atridia Pty Ltd.